Whitehawk Therapeutics Inc
WHWK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | -$0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 6.7% | 60.1% | 1,258.6% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -108% | -112.4% | -123.4% | -1,656.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -248.7% | -294.7% | -386.4% | -3,299.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -245.1% | -270% | -397.7% | -9,829.5% |
| EPS Diluted | -2.36 | -2.44 | -2.69 | -12.41 |
| % Growth | 3.3% | 9.3% | 78.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |